• Je něco špatně v tomto záznamu ?

Novel neurosteroid pregnanolone pyroglutamate suppresses neurotoxicity syndrome induced by tetramethylenedisulfotetramine but is ineffective in a rodent model of infantile spasms

CR. Chern, M. Lauková, A. Schonwald, E. Kudová, H. Chodounská, CJ. Chern, MP. Shakarjian, J. Velíšková, L. Velíšek

. 2023 ; 75 (1) : 177-188. [pub] 20221123

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23004387

Grantová podpora
R21NS118337-01 NINDS NIH HHS - United States
R21NS084900 NINDS NIH HHS - United States
R01NS092786 NINDS NIH HHS - United States
R21NS118337-01 NINDS NIH HHS - United States
R21NS084900 NINDS NIH HHS - United States
R01NS092786 NINDS NIH HHS - United States

BACKGROUND: Neurosteroids are investigated as effective antidotes for the poisoning induced by tetramethylenedisulfotetramine (TMDT) as well as treatments for epileptic spasms during infancy. Both these conditions are quite resistant to pharmacotherapy; thus, a search for new treatments is warranted. METHODS: In this study, we determined the efficacy of two novel neurosteroids, pregnanolone glutamate (PAG) and pregnanolone pyroglutamate (PPG), and tested these drugs in doses of 1-10 mg/kg (ip) against the TMDT syndrome and in our rodent model of infantile spasms. RESULTS: Only PPG in doses 5 and 10 mg/kg suppressed the severity of the TMDT syndrome and TMDT-induced lethality, while the 1 mg/kg dose was without an effect. Interestingly, the 1 mg/kg dose of PPG in combination with 1 mg/kg of diazepam was also effective against TMDT poisoning. Neither PAG nor PPG were effective against experimental spasms in the N-methyl-D-aspartate (NMDA)-triggered model of infantile spasms. CONCLUSIONS: While evidence suggests that PAG can act through multiple actions which include allosteric inhibition of NMDA-induced and glycine receptor-evoked currents as well as augmentation of ɣ-aminobutyric acid subtype A (GABAA) receptor-induced currents, the agent appears to neither have the appropriate mechanistic signature for activity in the infantile spasm model, nor the adequate potency, relative to PPG, for ameliorating the TMDT syndrome. The full mechanisms of action of PPG, which may become a potent TMDT antidote either alone or in combination with diazepam are yet unknown and thus require further investigation.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23004387
003      
CZ-PrNML
005      
20230427095922.0
007      
ta
008      
230418s2023 sz f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s43440-022-00437-1 $2 doi
035    __
$a (PubMed)36422805
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Chern, Chian-Ru $u Department of Cell Biology and Anatomy, New York Medical College, Valhalla, NY, USA
245    10
$a Novel neurosteroid pregnanolone pyroglutamate suppresses neurotoxicity syndrome induced by tetramethylenedisulfotetramine but is ineffective in a rodent model of infantile spasms / $c CR. Chern, M. Lauková, A. Schonwald, E. Kudová, H. Chodounská, CJ. Chern, MP. Shakarjian, J. Velíšková, L. Velíšek
520    9_
$a BACKGROUND: Neurosteroids are investigated as effective antidotes for the poisoning induced by tetramethylenedisulfotetramine (TMDT) as well as treatments for epileptic spasms during infancy. Both these conditions are quite resistant to pharmacotherapy; thus, a search for new treatments is warranted. METHODS: In this study, we determined the efficacy of two novel neurosteroids, pregnanolone glutamate (PAG) and pregnanolone pyroglutamate (PPG), and tested these drugs in doses of 1-10 mg/kg (ip) against the TMDT syndrome and in our rodent model of infantile spasms. RESULTS: Only PPG in doses 5 and 10 mg/kg suppressed the severity of the TMDT syndrome and TMDT-induced lethality, while the 1 mg/kg dose was without an effect. Interestingly, the 1 mg/kg dose of PPG in combination with 1 mg/kg of diazepam was also effective against TMDT poisoning. Neither PAG nor PPG were effective against experimental spasms in the N-methyl-D-aspartate (NMDA)-triggered model of infantile spasms. CONCLUSIONS: While evidence suggests that PAG can act through multiple actions which include allosteric inhibition of NMDA-induced and glycine receptor-evoked currents as well as augmentation of ɣ-aminobutyric acid subtype A (GABAA) receptor-induced currents, the agent appears to neither have the appropriate mechanistic signature for activity in the infantile spasm model, nor the adequate potency, relative to PPG, for ameliorating the TMDT syndrome. The full mechanisms of action of PPG, which may become a potent TMDT antidote either alone or in combination with diazepam are yet unknown and thus require further investigation.
650    _2
$a zvířata $7 D000818
650    12
$a křeče u dětí $x chemicky indukované $x farmakoterapie $7 D013036
650    _2
$a pregnanolon $x škodlivé účinky $7 D011280
650    _2
$a kyselina pyrrolidonkarboxylová $7 D011761
650    12
$a neurosteroidy $7 D000081227
650    _2
$a N-methylaspartát $x toxicita $x terapeutické užití $7 D016202
650    _2
$a hlodavci $7 D012377
650    _2
$a diazepam $x farmakologie $7 D003975
650    12
$a neurotoxické syndromy $7 D020258
650    _2
$a kyselina glutamová $7 D018698
650    _2
$a spasmus $7 D013035
655    _2
$a časopisecké články $7 D016428
700    1_
$a Lauková, Marcela $u Department of Cell Biology and Anatomy, New York Medical College, Valhalla, NY, USA $u Institute of Experimental Endocrinology, Biomedical Research Center of the Slovak Academy of Science, Bratislava, Slovakia
700    1_
$a Schonwald, Antonia $u Department of Cell Biology and Anatomy, New York Medical College, Valhalla, NY, USA
700    1_
$a Kudová, Eva $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Chodounská, Hana $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Chern, Chian-Jiang $u Department of Cell Biology and Anatomy, New York Medical College, Valhalla, NY, USA
700    1_
$a Shakarjian, Michael P $u Department of Cell Biology and Anatomy, New York Medical College, Valhalla, NY, USA $u Department of Public Health, Environmental Health Science Program, New York Medical College, Valhalla, NY, USA $u Department of Medicine, Division of Pulmonary and Critical Care Medicine, Rutgers-Robert Wood Johnson Medical School, 675 Hoes Ln W, Piscataway, NJ, 08854, USA
700    1_
$a Velíšková, Jana $u Department of Cell Biology and Anatomy, New York Medical College, Valhalla, NY, USA $u Department of Obstetrics and Gynecology, New York Medical College, Valhalla, NY, USA $u Department of Neurology, New York Medical College, Valhalla, NY, USA
700    1_
$a Velíšek, Libor $u Department of Cell Biology and Anatomy, New York Medical College, Valhalla, NY, USA. Libor_Velisek@nymc.edu $u Department of Neurology, New York Medical College, Valhalla, NY, USA. Libor_Velisek@nymc.edu $u Department of Pediatrics, New York Medical College, Valhalla, NY, USA. Libor_Velisek@nymc.edu $1 https://orcid.org/000000032805349X $7 kup19940000106601
773    0_
$w MED00165879 $t Pharmacol. Reports $x 2299-5684 $g Roč. 75, č. 1 (2023), s. 177-188
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36422805 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230418 $b ABA008
991    __
$a 20230427095916 $b ABA008
999    __
$a ok $b bmc $g 1924834 $s 1190596
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 75 $c 1 $d 177-188 $e 20221123 $i 2299-5684 $m Pharmacol. Reports $n Pharmacol. Rep. $x MED00165879
GRA    __
$a R21NS118337-01 $p NINDS NIH HHS $2 United States
GRA    __
$a R21NS084900 $p NINDS NIH HHS $2 United States
GRA    __
$a R01NS092786 $p NINDS NIH HHS $2 United States
GRA    __
$a R21NS118337-01 $p NINDS NIH HHS $2 United States
GRA    __
$a R21NS084900 $p NINDS NIH HHS $2 United States
GRA    __
$a R01NS092786 $p NINDS NIH HHS $2 United States
LZP    __
$a Pubmed-20230418

Najít záznam

Citační ukazatele

Možnosti archivace